Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday. Google ...

Google-Backed AI Drug Discovery Startup Raises $600 Million (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Thrive Capital led the financing round, with participation from Google Ventures, and follow-on capital from existing backer, Alphabet. Credit: SOPA Images via Getty Images. Isomorphic Labs has raised ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital ...